233 related articles for article (PubMed ID: 21978988)
1. The formulation of polyhedral boranes for the boron neutron capture therapy of cancer.
Calabrese G; Nesnas JJ; Barbu E; Fatouros D; Tsibouklis J
Drug Discov Today; 2012 Feb; 17(3-4):153-9. PubMed ID: 21978988
[TBL] [Abstract][Full Text] [Related]
2. Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.
Nakamura H
Future Med Chem; 2013 Apr; 5(6):715-30. PubMed ID: 23617433
[TBL] [Abstract][Full Text] [Related]
3. Maximum therapeutic depth in thermal neutron capture therapy.
Allen BJ
Strahlenther Onkol; 1993 Jan; 169(1):34-41. PubMed ID: 8434338
[TBL] [Abstract][Full Text] [Related]
4. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of conjugates of polyhedral boron compounds with tumor-seeking molecules for neutron capture therapy.
Bregadze V; Semioshkin A; Sivaev I
Appl Radiat Isot; 2011 Dec; 69(12):1774-7. PubMed ID: 21531143
[TBL] [Abstract][Full Text] [Related]
6. Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents.
Bregadze VI; Sivaev IB; Glazun SA
Anticancer Agents Med Chem; 2006 Mar; 6(2):75-109. PubMed ID: 16529534
[TBL] [Abstract][Full Text] [Related]
7. The synthesis and use of boronated amino acids for boron neutron capture therapy.
Kabalka GW; Yao ML
Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
[TBL] [Abstract][Full Text] [Related]
8. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
9. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
[TBL] [Abstract][Full Text] [Related]
11. Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents.
Marepally SR; Yao ML; Kabalka GW
Future Med Chem; 2013 Apr; 5(6):693-704. PubMed ID: 23617431
[TBL] [Abstract][Full Text] [Related]
12. New approach to incorporation of boron in tumor-seeking molecules.
Sivaev IB; Semioshkin AA; Bregadze VI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
[TBL] [Abstract][Full Text] [Related]
13. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
14. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
[TBL] [Abstract][Full Text] [Related]
15. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
16. [Boron delivery system for neutron capture therapy of cancer].
Nakamura H
Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
[No Abstract] [Full Text] [Related]
17. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
18. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations.
Nguyen T; Brownell GL; Holden SA; Kahl S; Miura M; Teicher BA
Radiat Res; 1993 Jan; 133(1):33-40. PubMed ID: 8434111
[TBL] [Abstract][Full Text] [Related]
19. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
20. Interview with M Frederick Hawthorne.
Hawthorne MF
Future Med Chem; 2013 Apr; 5(6):627-32. PubMed ID: 23617426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
